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Abstract The complex structural and functional orga-
nisation of the brain warrants the application of high-
throughput approaches to study its functional alterations
in physiological and pathological conditions. Such
approaches have greatly benefited from advances in pro-
teomics and genomics, and from their combination with
computational modelling. They have been particularly
instrumental for the analysis of processes such as the
post-translational modification (PTM) of proteins, a crit-
ical biological process in the nervous system that remains
not well studied. Protein PTMs are dynamic covalent
marks that can be induced by activity and allow the
maintenance of a trace of this activity. In the nucleus,
they can modulate histone proteins and the components of
the transcriptional machinery, and thereby contribute to
regulating gene expression. PTMs do however need to be
tightly controlled for proper chromatin functions. This
review provides a synopsis of methods available to study
PTMs and protein expression based on high-throughput
mass spectrometry (MS), and covers basic concepts of
traditional ‘shot-gun’-based MS. It describes classical and
emerging proteomic approaches such as multiple reaction
monitoring and electron transfer dissociation, and their
application to the analyses of nuclear processes in the
brain.
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Abbreviations
CID Collision-induced dissociation
ECD Electron capture dissociation
ESI Electrospray ionisation
ETD Electron transfer dissociation
FFE Free-flow electrophoresis
HAT Histone acetyl transferase
HDAC Histone deacetylase
HMT Histone methyl transferase
HPLC High-performance liquid
chromatography
iTRAQ Isobaric tag for relative and absolute
quantitation
MALDI Matrix-assisted laser desorption
ionisation
MRM/SRM Multiple/selected reaction monitoring
MS Mass spectrometry
MS/MS Tandem mass spectrometry
m/z Mass-to-charge ratio
PTM Post-translational modification
PTP Proteotypic peptide
RP Reversed-phase
SCX Strong cationic exchange
SILAC/SILAM Stable isotope labelling of amino acids
in cell culture/in mammals
SUMO Small ubiquitin-like modifier
TOF Time of flight
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Introduction
Eukaryotic cells carry their genome within the nucleus,
a dedicated organelle with complex organisation and
structure. Although nuclear processes are extremely
important for cellular functions, their mechanisms and
modes of regulation remain only partially understood. An
important goal for the characterisation of nuclear organi-
sation and nuclear events is to identify and quantify the
proteins present in the chromatin, and in its different sub-
nuclear domains. Mass spectrometry (MS)-based proteo-
mics is a method of choice for such characterisation. It has
contributed tremendously to a better understanding of
nuclear functions and is expected to continue to advance
this understanding in the coming years.
It is well established that post-translational modifica-
tions (PTMs) on proteins are key to cellular signalling.
Most signalling pathways rely on reversible and site-
specific PTMs of proteins in most cellular compartments,
in particular the nucleus. When occurring on histone pro-
teins, PTMs can change chromatin structure, and positively
or negatively regulate transcriptional activity. PTMs such
as phosphorylation, acetylation, methylation and ubiquiti-
nation establish a specific ‘mark’ on histones called the
‘histone code’, which is dynamically induced and can
persist for long periods of time. The presence of these
PTMs alters the chromatin structure and affects the binding
of transcription factors, proteins that control gene activity,
to the DNA (Boi 2008). In the brain, histone PTMs are
critical for basic cellular processes such as activity-
dependent gene transcription, required for long-lasting
neuronal events, but also for complex brain functions such
as learning and memory. They are also emerging as critical
components of enduring effects on brain functions and
behaviour induced by early life experience, trauma, hor-
monal exposure or cognitive activation (Franklin and
Mansuy 2009; Graff and Mansuy 2008; McCarthy et al.
2009). The ability to interfere with histone PTMs using
drugs like for instance, inhibitors of histone deacetylases
(HDACs), is a promising approach to block gene activation
and transcription in pathologies such as cancer (Insinga
et al. 2005). However, a full and comprehensive under-
standing of regulatory mechanisms that control the histone
code in the nucleus is still required. The establishment of
appropriate methods to study these mechanisms is there-
fore, of primary importance for several areas of biology.
Proteomics in the brain and animal/cellular models
Advances in the sensitivity and temporal resolution of
MS-based proteomics has permitted quantitative analyses
of complex proteomes, and their change in response to cell
growth, activation, and death. Although fairly recent, the
application of MS methods to neuroscience has grown
significantly over the past years, and has allowed novel
investigations of biochemical processes in the nervous
system (Bayes and Grant 2009; Liao et al. 2009; Tweedie-
Cullen et al. 2007). Even though no single proteomic
strategy can lead to the full and routine analysis of the full
proteome of a given organism, the combined use of dif-
ferent techniques has allowed the extensive characterisa-
tion of sub-proteomes and organelles in several organisms.
Multiple studies have been carried out to systematically
identify proteins and their PTMs in given samples, and
many have provided quantitative measures.
Over the past few years, MS has been extensively
applied to cell-based systems and genetically engineered
mouse models for the study of biological processes.
Quantitative proteomic technologies when used in combi-
nation with cellular or animal models with, for instance,
controllable alterations in synaptic or nuclear functions
(Lee and Silva 2009) have allowed a better understanding
of specific proteins in these pathways. While complemen-
tary, they have their own advantages and limitations. Cell
culture-based systems provide more homogeneous cellular
populations and allow easier labelling than animal models
for quantitative proteomics (see below), but do not reca-
pitulate complex functions or processes such as behaviour.
In contrast, animals provide the most physiological models
of in vivo functions but are often too complex to allow
thorough proteomic analyses. Thus, depending on the
question under study, either one or a combination of these
models needs to be used. We have outlined below impor-
tant steps and parameters that need to be considered when
using cellular or animal models, and discuss some of the
data that has been generated with these models.
Fractionation of brain tissue and isolation of nuclear
sub-proteomes
An essential primary step in the analyses of biological
processes by proteomic methods is the preparation of
samples of maximal quality. Because cellular proteomes
are complex and contain proteins with a wide range of
abundance, fractionation is usually necessary to optimise
the identification of these proteins (Liao et al. 2009). This
is particularly true for tissues like the brain, which is rich in
lipids, and whose cells have distinct anatomical compo-
nents such as dendrites and synaptic terminals (Andersen
et al. 2005; Andersen et al. 2002; Andersen and Mann
2006; Gauthier and Lazure 2008; Tweedie-Cullen et al.
2007; Yates et al. 2005) (see Fig. 1). To analyse histones in
the nucleus it is common to first isolate nuclei by density
gradient centrifugation before extracting the histones
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themselves (Shechter et al. 2007). Several proteomic
studies have therefore used purified sub-cellular fractions
from the nucleus and nucleoli, the chromatin and chro-
mosome fractions, macromolecular complexes, enriched
preparations of interchromatin granule clusters, nuclear
envelope and pore clusters, or the nuclear matrix
(Albrethsen et al. 2009; Andersen et al. 2005; Beausoleil
et al. 2004; Saitoh et al. 2004; Schirmer and Gerace 2005;
Tweedie-Cullen et al. 2009).
In addition to sub-cellular fractionation, separation of
proteins or peptides after proteolytic digestion (see below)
is also usually necessary. Such separation can be achieved
by SDS-PAGE or high-pressure liquid chromatography
(HPLC) (Tannu and Hemby 2006). However, reversed-
phase (RP) chromatography, a method that fractionates
peptides via their differing hydrophobicity, is the most
common (Sandra et al. 2008). With highly complex sam-
ples, strong cationic exchange (SCX) chromatography can
also be used prior to RP-HPLC. SCX separates peptides
based on charge through the use of an increasing salt
gradient (typically KCl). It simplifies peptides mixtures and
thereby allows the identification of more peptides (Peng
et al. 2003). Imaging-MS techniques have also recently
been developed (McDonnell et al. 2009) and can provide
highly relevant information on the physiological context of
identified peptides and PTMs as tissue sections are directly
analysed in the mass spectrometer.
Protein identification in classical ‘shot-gun’ proteomics
Several methods can be used to identify proteins in frac-
tionated samples. The most classical approach conceptually
known as ‘bottom-up’ or ‘shot-gun’ proteomics consists of
firstly digesting the proteins into peptides using a protease
such as trypsin. The resulting peptide mixture is then
ionised and analysed by MS. Ionisation is usually per-
formed by electrospray (ESI), for which the sample is
directly sprayed into the mass spectrometer, or by MALDI
in which peptides are spotted onto a solid phase matrix, and
ionised via laser irradiation. The analysis of the ionised
samples then uses tandem MS (MS/MS), which in most
cases, allows the unambiguous identification of peptide
sequences and the precise localisation of PTMs on specific
residues (Steen and Mann 2004). Tandem MS has two
stages of data acquisition. First, the instrument determines
the mass to charge ratio (m/z) of all ions injected into
the spectrometer, then precursor ions are selected semi-
randomly based on their signal intensity, and are further
fragmented via a process known as collision-induced
Fig. 1 Flow of a typical MS-based proteomic experiment. a Neuro-
proteomic experiments generally begin with the processing of tissue
to obtain a mixture of proteins. The methods employed include
dissection, homogenisation, primary cell culture, cellular/protein
fractionation and affinity purification of protein complexes. b The
MS workflow begins by digesting protein samples with an enzyme
such as Glu-C or trypsin, and the resulting peptides are fractionated
using reversed-phase (RP), strong cationic exchange (SCX) HPLC or
free-flow electrophoresis (FFE) to reduce sample complexity.
Peptides are ionised and introduced into the MS via ESI or MALDI,
and their mass is determined by an MS precursor scan. Specific ions
are randomly selected and further fragmented to generate sequence
information that can be compared to sequences from in silico digested
protein sequence databases using search engines such as Mascot and
SEQUEST, for peptide and hence protein identification
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dissociation (CID). Fragmentation via CID results in the
preferential cleavage of adjacent amino acids at the peptide
bond. By measuring the mass of peptide fragments, it is
then possible to determine their sequence computationally
(Fig. 1).
Whilst ‘bottom-up’ analyses are most widely used,
a parallel ‘top-down’ approach can also be employed. It
involves the direct analysis of intact proteins without any
prior proteolytic digestion, and therefore allows the iden-
tification of combinatorial PTMs on individual proteins
(as long as these proteins do not exceed 70–100 kDa) and
the order in which PTMs occur (Siuti and Kelleher 2007;
Zabrouskov et al. 2006). Another methodological variant
known as ‘middle-down’ also exists, in which large prote-
olytic peptide fragments are generated using enzymes such
as Glu-C or Asp-N (as opposed to trypsin which generates
short fragments). It combines the benefits of ‘top-down’ and
‘bottom-up’ approaches, but allows the analysis of very
large proteins not suitable for top-down approaches alone.
One feature of ‘top-’ and ‘middle-down’ approaches is
their reliance on new methods of peptide fragmentation
based on electrons. When transferred to peptides, electrons
trigger highly selective, rapid and extensive fragmentation
of N–Ca bonds along the peptide/protein amide backbone.
Electron capture dissociation (ECD) is one of these meth-
ods, first reported in 1998 and subsequently developed into
electron transfer dissociation (ETD) (Syka et al. 2004).
ECD and ETD have been instrumental for the analysis of
large peptides ([30 amino acids) because they circumvent
the usually poor sequence coverage of such peptides by
CID. Thus, while peptide fragmentation by CID results in a
low number of fragment ions and limited sequence infor-
mation, ETD favours extensive fragmentation of the pro-
tein/peptide backbone and does not suffer from this
limitation (Evertts et al. 2010; Udeshi et al. 2008). ETD has
thereby enabled the application of ‘middle-down’ MS to
the analysis of histones, and the differentiation of histone
protein isoforms and their PTMs, which is difficult to
achieve by CID approaches (Garcia et al. 2007b; Mackay
et al. 2008). The extensive backbone fragmentation by
ETD/CID also improves the ability to localise PTMs to
specific residues, which is not possible without a large
number of fragment ions. Furthermore, ETD methods have
the advantage of retaining labile PTMs such as phosphor-
ylation or glycosylation, often cleaved off by CID, and
thereby making these PTMs more easily identifiable
(Garcia 2009; Kelleher et al. 1999).
Relative and absolute quantitative MS
An important limitation of most qualitative and mapping
proteomic studies is that they only show a static view of the
proteome, and do not provide any information about the
abundance of each protein, or about dynamic changes in
protein stoichiometry. Quantitative proteomic approaches
(see below) have, however, been developed in the past few
years to circumvent this limitation. They use two major
methods: differential isotopic labelling and label-free
quantification (Fig. 2) (for review see Bantscheff et al.
2007; Ong and Mann 2005). By measuring differences in
protein expression between samples, they allow compara-
tive analyses of molecular phenotypes and the detection of
changes in the relative and absolute protein abundance
resulting from manipulations such as cellular activation,
gene overexpression or knockout (Fig. 2).
Differential isotopic labelling
Differential isotopic labelling is currently the method of
choice for quantitative proteomics. It involves the chemical
labelling of isolated proteins and peptides with chemical
tags such as isobaric tag for relative and absolute
quantitation (iTRAQ), isotope-coded affinity tags (ICAT),
methyl-esterification/propionylation, or isotope-coded pro-
tein labelling (ICPL) (Leroy et al. 2010; Ong and Mann
2005; Pierce et al. 2007), or the in vivo incorporation of
isotope-labelled amino acids by metabolic labelling using
stable isotope labelling of amino acids in mammals
(SILAM) or stable isotope labelling of amino acids in cell
culture (SILAC) (Kruger et al. 2008; McClatchy et al. 2007;
Ong et al. 2002). Once labelled, samples are then combined
and analysed together (Fig. 2). In general, isotopic labelling
increases the peptide mass by a fixed amount, except for
iTRAQ, for which different isobaric tags are added to pep-
tides and are then released allowing for measurement upon
MS/MS analysis (Fig. 5 bottom). Relative quantitation is
performed by comparing the peak intensity between the
‘light’ and ‘heavy’ form of peptides in a MS precursor scan
(Fig. 2). Absolute quantification can also be determined by
adding calibrated amounts of isotopically labelled peptides
in the sample before MS analysis (Gerber et al. 2003;
Munton et al. 2007). Chemical labelling has the advantage
of being applicable to any cellular or tissue sample, unlike
SILAC/SILAM, which requires that cells or animals be
grown or fed with isotopically labelled medium/food.
Label-free quantitation
Label-free techniques do not make use of any isotopic
labelling of peptides. One method is based on spectral
counting (SC), which consists of determining the number
of spectra acquired for peptides derived from a given
protein. SC is a semi-quantitative method since it only
produces correlative data between spectra number and
protein abundance, as it does not measure the amount of
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protein directly (Liu et al. 2004). An alternative approach
to SC thought to be more accurate is global isoform per-
centage (GP). It consists of integrating the area under the
curve of each peptide and expressing it as a percentage of
the total integrated area for all peptides from the same
protein (America and Cordewener 2008; Phanstiel et al.
2008). Both methods, however, depend on a high level of
consistency between each MS run (Ong and Mann 2005),
which is often difficult to obtain. Thus at present, methods
based on stable isotopes are thought to be better and more
accurate than label-free methods.
Targeted proteomics: MRM/SRM
Classical ‘shot-gun’ proteomics is limited by the fact that it
only samples a fraction of the proteome usually biased
towards the higher end of the abundance scale (Picotti et al.
Fig. 2 Stable isotope labelling
approaches in quantitative MS
studies. The scheme outlines
typical labelling workflows in
quantitative proteomics from
the cell or tissue stage through
purification and protein
digestion to MS analysis. Green
(light) and orange (heavy)
solutions represent the two
different cell/tissue states that
have been differentially labelled
and can then be combined. The
stage where samples are
combined is indicated by both
solutions in one tube. When
samples have to be processed in
parallel, uncompensated
quantitation errors can occur.
Metabolic labelling
(a) strategies have the
advantage of fewer handling
steps as samples can be
combined at an early stage and
processed together and hence
reduce uncompensated losses. It
can however only be applied to
cell lines or organisms that can
be metabolically labelled.
Peptide (b) and protein
(c) labelling methods allow
samples to be combined at the
peptide and protein level,
respectively, and can be applied
to all samples. In addition,
synthetic peptides (d) can also
be spiked into the sample to
obtain absolute quantitation of
the level of specific peptides/
proteins. Isotopic labelling
results in a mass difference
(except for iTRAQ tags: see
Fig. 5) between peptides from
each sample. Upon MS analysis
the relative and/or absolute
quantitation of peptides in each
sample can be determined by
comparing their peak intensities
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2007). Recently, new ‘targeted’ MS approaches have been
developed in which the mass spectrometer is directed to
select and fragment specific ‘proteotypic’ peptides (PTPs),
which are unique to a specific protein and therefore, rep-
resent the most ‘informative’ peptides in a sample mixture
(Schmidt et al. 2009). Targeted proteomics can be thought
of as the MS equivalent of the traditional Western blot, in
that specific proteins are targeted and quantitated. Pio-
neering studies have shown the ability of selected reaction
monitoring (SRM)-based MS for the detection and quan-
titation of proteins over the whole range of cellular con-
centrations in unfractionated S. cerevisiae digests (Picotti
et al. 2009; Picotti et al. 2010). This study demonstrated
that comparative analyses of the protein amount of entire
but relatively simple proteomes or organelles across mul-
tiple samples are now possible. SRM provides a powerful
workflow for the development and use of quantitative
assays to monitor protein signalling networks and their
dynamics in sub-cellular compartments across multiple
samples and replicates (Fig. 3). Furthermore, SRM can
also be applied to specifically target and quantify peptides
with PTMs like phosphorylation (Unwin et al. 2005;
Williamson et al. 2006), ubiquitination (Mollah et al. 2007)
and acetylation (Griffiths et al. 2007). It is aided by the
increasingly comprehensive and high quality peptide
repositories, in which experimentally observed peptides are
made accessible (Fig. 3). Targeted MS studies therefore,
have the potential to generate more consistent and repro-
ducible datasets and enlarge the known proteome.
Analysis of changes in the proteome
Proteomic approaches now allow the routine monitoring
of thousands of proteins and their dynamics in different
sub-cellular compartments, tissues and brain regions
(Baumgartel et al. 2008; Olsen et al. 2010; Trinidad et al.
2008). Methods like SILAC, based on the incorporation of
stable isotopes into proteins through pulse labelling, or the
feeding of cells or animals, are available to trace proteins
and determine their turnover and movement through spe-
cific sub-cellular organelles. Thus, SILAC was successfully
used to reveal changes in the nuclear proteome during
apoptosis (Hwang et al. 2006), DNA damage (Bennetzen
et al. 2010), basal protein turnover in the nucleolus (Lam
et al. 2007), after adenovirus infection (Lam et al. 2010), or
treatment with inhibitors of transcription, proteasome
activity or protein kinases (Andersen et al. 2005, 2002).
SILAC also helped identify the target proteins of micro-
RNA-1 (mRNA-1), and demonstrated that it regulates the
level of several different proteins (Vinther et al. 2006).
iTRAQ was also used to monitor proteome changes in the
amygdala resulting from overexpression of the transcrip-
tion factor Zif268 (Baumgartel et al. 2009).
The characterisation of the flux of proteins in specific
cellular organelles has become an important question in
biology. So-called ‘spatial proteomics’ using whole-cells
has therefore been developed for this purpose. It has been
used to study the relative steady-state distribution of proteins
in the cytoplasm, nucleus and nucleolus, and their changes
upon DNA damage (Boisvert et al. 2010), complementing
data generated in other studies on changes in phosphoryla-
tion during the same process (Bennetzen et al. 2010).
Analysis of PTMs
Signalling pathways in the cytoplasm and the nucleus are
extremely complex, and their components are subjected to
multiple PTMs and ‘cross-talk’ between these PTMs.
Identifying these PTMs and their ‘cross-talk’ is a difficult
task because PTMs are covalently attached, labile, and
usually present at a sub-stoichiometric level. They often
affect only a small fraction of target proteins on a given
Fig. 3 Workflow to quantitate signalling pathways in the nucleus
using MRM/SRM. Proteotypic peptides are selected for the protein/s
of interest and for housekeeping proteins needed for normalisation of
the data. Optimal proteotypic peptides are selected using pre-existing
databases of MS detectable peptides (NIST/PeptideAtlas), or alterna-
tively can be predicted using software tools (PeptideSieve). Transi-
tions are best optimised and selected by analysing synthetic versions
of all selected proteotypic peptides. Once established, an MRM assay
can be applied to peptide samples derived from different experimental
conditions to quantitate the pathway/proteins of interest. Absolute
quantitation can be achieved by spiking isotopically labelled variants
for each peptide into the sample (scheme adapted from Lange et al.
2008)
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residue, and are hard to detect in complex samples that
contain thousands of proteins. They therefore need to be
enriched, for instance by affinity purification or chroma-
tography, especially in the case of phosphorylation
(Tweedie-Cullen et al. 2007). While specific workflows
need to be developed for analysing each PTM, they can
often be applied to different PTMs with only small chan-
ges, for instance by using PTM-specific antibodies (anti-
phospho, anti-acetyl or anti-ubiquitin) (Zhao and Jensen
2009). Finally, the identification using MS of previously
unknown PTMs such as acetylation of serines and arginines
(Mukherjee et al. 2007), or formylation (Wisniewski et al.
2008), butyrylation and propionylation (Chen et al. 2007)
of lysines on histone proteins has opened new perspectives
for important discoveries on cellular signalling in the future
(Fig. 4).
Phosphorylation, acetylation and methylation
Although protein phosphorylation is thought to be a cell-
wide regulatory mechanism for protein functions, recent
quantitative proteomic studies have shown that it prefer-
entially targets nuclear proteins (Olsen et al. 2006). Many
protein phosphatases are enriched in the nucleus, and some
are even present exclusively in this sub-cellular compart-
ment (Moorhead et al. 2007). Several strategies have
been developed in the past years to enrich and analyse
phosphopeptides in different sub-cellular compartments
(Bodenmiller et al. 2007; Tweedie-Cullen et al. 2007)
including the nucleus (Beausoleil et al. 2004; Liao et al.
2008; Tweedie-Cullen et al. 2009; Villen et al. 2007).
Approaches based on iTRAQ have quantified changes in
phosphorylation in synaptic terminals from different brain
regions (Coba et al. 2009; Trinidad et al. 2008) while
SILAC in cell culture (Bennetzen et al. 2010; Olsen et al.
2006) or SILAM in young mice (Liao et al. 2008) revealed
the extent of phosphorylation in the nucleus. Advance-
ments in methodologies have allowed the simultaneous
monitoring of thousands of phosphorylation sites and
proteins, and greatly enlarged phosphorylation datasets.
Notable recent studies have quantified 20,443 phosphory-
lation sites during mitosis (Olsen et al. 2010), 5,204 sites
during DNA damage (Bennetzen et al. 2010), and dem-
onstrated the ability to monitor phosphorylation dynamics
at sub-millisecond timescales (Dengjel et al. 2007); all of
which was inconceivable just a few years ago.
Along with protein phosphorylation, acetylation is
another extremely prevalent PTM that occurs on proteins in
most sub-cellular compartments. Acetylation of lysine
residues and of the N terminus is the most frequent PTM on
histone proteins (Kouzarides 2007; Tweedie-Cullen et al.
2009). However, despite this prevalence, the identity and
specificity of the enzymes that generate and regulate
acetylation on selected residues are still poorly understood.
Furthermore, it is only recently that the important regula-
tory role of acetylation has been recognised. Quantitative
MS studies have revealed that it goes far beyond histone
regulation and DNA repair and that, like phosphorylation,
it is not only prevalent on nuclear proteins but it also affect
major nuclear processes, and cytoplasmic macromolecular
complexes (Choudhary et al. 2009). Intriguingly, recent
MS studies have also demonstrated its presence on serine
and threonine residues, suggesting the possibility that it may
interfere with phosphorylation (Mukherjee et al. 2007).
Large modifications: ubiquitin, and related modifiers
Proteins can also be modified by conjugation to other
proteins, in particular to ubiquitin and the small ubiquitin-
like modifier (SUMO). Ubiquitin is a small protein of
Fig. 4 Strategy to analyse histones and histone PTMs. After isolation
of nuclei and acid extraction of bulk histones, histone sub-types can
be separated using RP-HPLC. Individual histones can then be
analysed by ‘bottom-up’, ‘middle-down’ or ‘top-down’ strategies.
Typical ‘top-down’ methods employ ETD or ECD for intact protein
fragmentation. ‘Bottom-up’ and ‘middle-down’ methods involve the
enzymatic digestion of intact histones into peptides of varying lengths
depending on the specificity of the enzyme used. These peptides can
then be analysed by ETD/ECD or CID. In all methods, MS/MS data
generated allows the determination of peptide sequence and the
location of any PTMs. In addition, quantitation can be achieved
through chemical/metabolic labelling of histone proteins, or alterna-
tively through label-free means
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76 amino acids often attached to lysine by ubiquitin
ligases (Kirkpatrick et al. 2005a). Although classically
associated with protein degradation (Ciechanover 2005),
ubiquitination is also essential for cellular signalling. MS
studies have shown that it is relatively abundant on his-
tone proteins (Tweedie-Cullen et al. 2009), supporting the
idea that it is a key component of the histone code
(Briggs et al. 2002). Ubiquitinated substrates in proteomic
experiments can be isolated via affinity purification of
tagged substrates (Kirkpatrick et al. 2005b), as was done
in a transgenic mouse line engineered to express poly-
histidine-tagged ubiquitin (Tsirigotis et al. 2001). None-
theless, ubiquitin can also be detected in simple histone
samples without prior enrichment using MS (Beck et al.
2006; Tweedie-Cullen et al. 2009). Its size does make its
analyses by MS more difficult than with other smaller
PTMs. However, it can be cleaved by trypsin and there-
fore be examined by ‘bottom-up’ proteomic studies
(Denis et al. 2007). Nonetheless when studying ubiquitin
by MS, workflows must be adjusted because commonly
used reagents such as iodoacetamide can generate chem-
ical artefacts that are indistinguishable from ubiquitin
(Nielsen et al. 2008).
In addition to ubiquitin, other ubiquitin-like proteins
such as SUMO can be added to proteins, in particular in the
nucleus. Sumoylation exclusively modulates non-prote-
asomal endpoints. It is thought to be primarily a nuclear or
perinuclear reaction because sumoylation enzymes and
their substrates are predominant at the nuclear membrane
and within the nucleus (Hay 2005). Proteomic analyses
based on various tagged versions of SUMO-1 and SUMO-2
in human cells have identified multiple SUMO substrates,
involved in chromatin organisation, transcription, and RNA
metabolism (Andersen et al. 2009; Li et al. 2004; Vassileva
and Matunis 2004; Vertegaal et al. 2004; Zhao et al. 2004).
SUMO-1 was reported to be primarily nuclear whilst
SUMO-2/3 can occur in the nucleus and the cytoplasm
(Manza et al. 2004; Melchior et al. 2003). Nuclear proteins
such as the transcription factor NF-jB can be sumoylated
or ubiquitinated on the same residue, with SUMO acting as
a protein stabiliser and preventing its degradation by the
proteasome (Desterro et al. 1998). Several studies have
indeed demonstrated the tight regulatory link between
these two PTMs (Schimmel et al. 2008).
Proteomics has greatly expanded the knowledge on
PTMs in the nucleus, in particular their abundance and
dynamic regulation in different conditions and during
development. Their preponderance on nuclear proteins
suggests that they do not work in isolation and multiple
signalling pathways may use all or most of these PTMs in
combination. Therefore, quantitative MS studies are
increasingly required to take into account all PTMs when
analysing signalling pathways.
Combinatorial PTMs: the ‘histone code’
The histone code hypothesis proposes that histone PTMs
co-occur in specific combinations and patterns, and are
linked by multiple reciprocal and controlled ‘cross-talks’
(Latham and Dent 2007; Wang et al. 2008). Histone PTMs
contribute to chromatin remodelling and serve in part, to
bind effector proteins. In the nucleus, the combinatorial
assembly of chromatin regulatory complexes is critical for
reading and maximising the information provided by his-
tone PTMs (Wu et al. 2009). The histone code is thus one
mode of the epigenetic regulation of gene expression
(Campos and Reinberg 2009; Jenuwein and Allis 2001).
Because of this code’s complex and dynamic nature,
which makes it rapidly and specifically changing in dif-
ferent cells, it is difficult to study and remains not fully
understood. However, specific aspects of the histone code
can be examined by MS approaches, and several studies
have demonstrated the potential of these approaches for
investigating the histone code. ‘Bottom-up’ MS methods
allowed the successful generation of comprehensive maps
of isolated histones (Garcia et al. 2006, 2007c; Tweedie-
Cullen et al. 2009; Wisniewski et al. 2007). Likewise,
MS/MS based on ETD led to the analyses of intact histones
or large proteolytic fragments (Garcia et al. 2007b), pro-
viding a map of PTMs on individual histones, essential to
fully capture the dynamic interactions and functions of
histones. It also distinguished PTMs on variants of histones
such as H2A, H2B (Boyne et al. 2006; Eliuk et al. 2010;
Siuti et al. 2006), H3.2 and H4, and their potential com-
binatorial code (Garcia et al. 2007b; Young et al. 2009).
Although technically more difficult and challenging,
quantitative proteomic analyses of multi-site PTMs have
also been performed. Quantitation of histones cannot be
done by chemical labelling based on iTRAQ because it
targets the free amine of the N terminus and lysines, which
also carry multiple PTMs and thus interfere with labelling.
Alternative methods based, for instance, on SILAC
(Bonenfant et al. 2007; Zee et al. 2010), propionylation of
unmodified lysines (Garcia et al. 2007a; Plazas-Mayorca
et al. 2009), or label-free methods (Beck et al. 2006; Fraga
et al. 2005; McKittrick et al. 2004) can however be used.
Recent quantitative and semi-quantitative studies have
exploited these methods to examine the effect on histone
PTMs of HDAC inhibitors (Beck et al. 2006), the cell cycle
(Bonenfant et al. 2007), differences between mouse strains
(Jung et al. 2010), and the interplay between neighbouring
PTMs (Fischle et al. 2005; Garcia et al. 2007b).
Overall, the knowledge of the histone code gained by
MS is expected to greatly advance the understanding of the
epigenetic mechanisms of gene regulation. Interesting
extensions have already emerged that further exploit MS
methodologies or the data generated. For instance, the
1124 R. Y. Tweedie-Cullen, I. M. Mansuy
123
nature of chromatin-binding proteins associated with his-
tone tails has been examined. Using a combinatorial pep-
tide library containing 5,000 PTM-randomised peptides
derived from H3, a study probed the interaction between
six binding modules reading H3K4 methylation and chro-
matin, and identified potential additional PTMs regulating
these interactions (Garske et al. 2008, 2010). Workflows
used for histone studies (see Fig. 4) have also been utilised
for the analysis of other proteins rich in PTMs. ‘Top-’,
‘middle-down’ and ‘bottom-up’ MS methods have thus
been used to determine the combinatorial code of PTMs on
the chromatin-associated high mobility group protein
HMG1a (Young et al. 2010).
Analysis of the composition and alterations of protein
complexes
Vital cellular functions such as DNA replication, tran-
scription and mRNA translation require the coordinated
action of multiple proteins assembled in complexes with
different compositions and structures (D’Alessio et al.
2009; Hager et al. 2009). Such multi-protein complexes
also underlie the development of complex organs like the
central nervous system (Ryan and Grant 2009), and their
disruption can lead to brain diseases (Emes et al. 2008;
Laumonnier et al. 2007). The analysis of protein complexes
and protein–protein interaction networks, and the dynamics
of these networks across time and in different cells, are
therefore of central importance in biological research
(Fig. 5).
Different approaches have been used to characterise
multi-protein complexes but typical workflows have com-
bined affinity purification with MS. Here, multi-protein
complexes are isolated directly from cell lysates or sub-
cellular compartments through one or more affinity puri-
fication steps, and their components are analysed by MS.
The advantage of this approach is that it can be performed
in near-physiological conditions directly from nuclear
extracts, which preserves proteins and biochemical modi-
fications such as PTMs (Gingras et al. 2007; Pflieger et al.
2008; Ranish et al. 2003). Whilst the large-scale analysis of
chromatin-associated proteins has proven technically dif-
ficult, proteomic workflows have successfully investigated
protein complexes in the nucleus, for instance chromatin-
remodelling complexes such as the SWI/SNF-like (Lessard
et al. 2007), complexes bound to histone H4 and H3 tail
(Chan et al. 2009; Choi et al. 2007), the RNA Pol II
holoenzyme (Jeronimo et al. 2004), the transcription factor
GATA-1 (Rodriguez et al. 2006), and the protein phos-
phatase PP1 (Trinkle-Mulcahy et al. 2006). Cell culture-
based studies have also looked at binding partners of the
Fig. 5 Quantitative analysis of changes in protein complex stoichi-
ometry using iTRAQ. Desired treatment of cells or extraction of
tissue from different conditions is followed by isolation of protein
complexes using affinity purification and proteolysis using trypsin.
Isobaric iTRAQ tags are chemically added to the N terminus and
lysines of every peptide and samples from different times or
conditions are labelled with a different iTRAQ tag (4 shown, up to
8 possible), and then combined. Samples can then be analysed via
ESI- or MALDI-MS. MS/MS analysis of iTRAQ labelled samples
generates a spectrum that yields the sequence of the peptide, and
iTRAQ reporter ions (red peak: expanded in close-up), which can be
seen in the low mass range (114–121 m/z). Comparison of the peak
intensities for each reporter ion allows quantitation. In the example
shown, iTRAQ analysis would allow the elucidation of changes in the
proteins attached to the bait protein (shown as a blue oval) over time
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protein phosphatases PP2A, PP4 and PP6, which play
important roles in the nucleus, in whole cell lysates (Chen
and Gingras 2007; Goudreault et al. 2009; Mumby 2007).
A major limitation of many of these approaches how-
ever, is that the resulting view of the protein complexes is
static and does not take into account dynamic changes. The
use of quantitative MS approaches based on multiplex tags
can however allow the determination not only of the spe-
cific composition of complexes, but also changes in their
composition, and in the abundance of their components
(Gingras et al. 2007; Ranish et al. 2003). Another important
aspect often not addressed in high-throughput studies is the
stoichiometry of these components, important for under-
standing the structural organisation of protein assemblies.
One strategy to determine stoichiometry is to combine
protein complex isolation with isotope-based absolute
quantitative proteomics. If all components of a complex are
known, synthetic peptides can be generated to monitor the
abundance of each protein in the complex. These can either
be synthesised with heavy isotopes and then mixed in with
the unlabelled sample using an absolute quantitation
(AQUA) approach (Gerber et al. 2003), or labelled with
iTRAQ or a similar reagent in parallel to the samples
(Munton et al. 2007). Such an approach was successfully
used in the nucleus to determine the stoichiometry of the
human spliceosomal U1 small nuclear ribonucleoprotein
complex (Hochleitner et al. 2005). Quantitative studies
have also enabled the analysis of the protein dynamics of
the kinetochore during mitosis (Akiyoshi et al. 2009),
H2AX-associated proteins during DNA damage and repair
(Du et al. 2006), and the Mediator complex during tran-
scriptional activity (Paoletti et al. 2006). High-throughput
approaches that quantitatively analyse protein interactions
promise to accelerate the understanding of protein com-
plexes in the future (Wepf et al. 2009). Their application in
combination with methods like chromatin immunoprecip-
itation (ChiP) will be instrumental to the identification of
the binding location of protein complexes to the DNA, and
of the nature and number of binding partners (Collas and
Dahl 2008; Le Guezennec et al. 2005).
Bioinformatics and the integration of proteomic data
High-throughput studies of biological systems are provid-
ing a rapidly accumulating wealth of highly accurate
qualitative and quantitative data. The visualisation and
integration of this data is the key to their analysis and
comprehension. Many new tools now exist or are being
developed to help process, integrate and use these large-
scale datasets (for a review see Gehlenborg et al. 2010).
In proteomic studies, visualisation has been instrumental to
the understanding of biological systems such as signalling
via PTMs (Choudhary et al. 2009; Olsen et al. 2006, 2010),
the role of multi-protein complexes in evolution and dis-
ease (Pocklington et al. 2006; Ryan and Grant 2009), and
for the integration of disparate data (Leung et al. 2003).
The tools available are diverse and range from the opti-
misation and automation of common workflows, through to
specifically dealing with, and aiding, the analysis of protein
interaction networks, protein expression and PTM profil-
ing, and modelling cellular pathways (Gehlenborg et al.
2010). The availability of large-scale proteomic datasets
has also had the added benefit of providing training sets for
improving the accuracy of prediction tools, e.g. for PTMs
such as acetylation (Basu et al. 2009) and phosphorylation
(Schwartz and Gygi 2005). Increasingly, data generated in
biology is being used in meta-models of entire systems
such as the whole brain in the Blue Brain Project (Markram
2006).
Conclusions
Proteomics is leading a new way in the interpretation of
molecular studies in organelles such as the nucleus, moving
away from single genes to networks of molecules, thereby
providing a logical and innovative framework to study
physiology and behaviour. ‘Shot-gun’ and emerging pro-
teomic techniques have proven to be a driving force in
neuroscience research. The advantages of analysing thou-
sands of proteins in a single experiment have led to the
identification of novel proteins and PTMs involved in
cellular functions. Ultimately, the rapid ascension of sys-
tems biology and bioinformatics will potentially allow us
to model biological processes and determine in silico how
drugs and manipulations affect them in their entirety.
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